Study detailsThe PEACE study follow this web-site.

Study detailsThe PEACE study , a randomized, multicenter trial is trandolapril vs placebo in 8290 patients with stable coronary artery disease follow this web-site . SPLA2 activity identified individuals at increased risk of cardiovascular death and the combination of CVD, myocardial infarction or stroke during 5 years of follow-up. Adjusted for fundamental differences, people had. With the highest levels of sPLA2 activity, a 78 percent higher risk of CVD and a 56 percent higher risk of CVD, MI or stroke than patients with the lowest sPLA2 activity In addition, sPLA2 activity marker for marker for risk prediction than other established biomarkers, including C-reactive protein and lipoprotein-associated phospholipase A2.

About the EndoBarrier Gastrointestinal LinerThe patented EndoBarrier Gastrointestinal Liner is an advanced experimental, non-surgical medical device on the EndoBarrier Technology platform for the treatment of type 2 diabetes and obesity is based. Placed the EndoBarrier Gastrointestinal Liner in the GI tract endoscopically a barrier between a barrier between food and the wall of the intestine. Physicians may believe that preventing food to come into contact with the intestinal wall, the activation of hormonal signals that its origin in the intestine to change, and mimicking the effects of a Roux-en - Y gastric bypass procedure without surgery. A growing body of preclinical and clinical data support the potential for EndoBarrier Gastrointestinal Liner dramatically change the treatment landscape for people with type 2 diabetes, obese people are at risk for type 2 diabetes and people with severe weight problems.

A recent analysis from THE SAGE GROUP releases concludes that atherosclerotic peripheral artery disease affects more than 20 million into Indian. Both PAD and CLI. Substantial and considerably underestimates problems of of the Indian economy and healthcare - 'Though it is generally believed in that PAD a ''be disease with a lower prevalence the Asian Indians, our research indicates that it is not case, 'West said Mary L. Author of the report. 'PAD seem plaguing Native find at similar rates as Europe and the U.S. Populations of the same Old group and risk factors,'she continued. 'The deciding factor the age, 'Yost explained in. 'Older age is as a of the greatest famous risk factor both PAD and CLI. India a much younger public with average age of 23 years when the average age in the U.S., 35 in Germany and 40'. We believe, known as peripheral vascular disease or peripheral arterial disease . Represent a reduction in blood flow to lower limb of atherosclerosis. - Add critical limb ischemia blood supply be so inadequate that ulcerations and gangrene appear. Once PAD was CLI, proceeded risks of risk the loss of limb and mortality in. Following six months, some 20 percent of patients with CLI to die, another 40 percent amputation amputation. 'CLI 'end-stage 'Peripheral Arterial Disease is,'Ms. Yost.

follow this web-site

We estimates on the number which PAD PAD and CLI India on the diabetic method of ' that we so far employs be based Western Europe and the U.S., Yost continued. in absence of large, population-based studies, we believe, Yost is diabetes method of estimation of assessment of lower extremity prevalence of disease, explains Yost.